2024 first quarter consolidated sales
2024/04/16 - Financial public releases
2024 first quarter consolidated sales
2024/04/16 - Financial public releases
Virbac acquired Sasaeah, a leading animal health player in Japan.
2024/04/02 - Financial public releases
On April 1, we successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.
2023 Annual results
2024/03/19 - Financial public releases
Annual Ordinary General Meeting
From 2024/06/21
Annual Ordinary General Meeting
2024 second quarter sales
From 2024/07/16
2024 second quarter sales
(quiet period from July 2, 2024)
2024 interim result
From 2024/09/13
2024 interim result
(quiet period from August 16, 2024)
2024 first quarter sales
From 2024/04/16
2024 first quarter sales
(quiet period from April 2, 2024)
SFAF meeting - 2023 financial & strategic information
From 2024/03/20
2023 results
From 2024/03/19
2023 results
(quiet period from February 20, 2024)